Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Welsh

Showing results (1-10 of 328) with videos related to

Pageof 33
Sort By:
Hypertension (Dallas, Tex. : 1979)|December 28, 2017
Correlating Changes in Metabolic Status With Arterial Health: Modest Associations but Any Clinical Implications?Paul Welsh
European Heart Journal|March 10, 2022
Risk scoring in secondary prevention: a basis for informed clinical decisions in the context of ever-expanding treatmentsNaveed Sattar, Paul Welsh
European Heart Journal|May 28, 2020
The obesity paradox in secondary prevention: a weighty intervention or a wait for more evidence?Naveed Sattar, Paul Welsh
BMJ (Clinical Research Ed.)|April 3, 2014
Vitamin D and chronic disease preventionPaul Welsh, Naveed Sattar
Clinical Chemistry|November 25, 2022
To ApoB or Not to ApoB: New Arguments, but Basis for Widespread Implementation Remains ElusivePaul Welsh, Naveed Sattar
BMJ (Clinical Research Ed.)|November 20, 2014
Vitamin D genes and mortalityPaul Welsh, Naveed Sattar
Arthritis Care & Research|July 1, 2010
Association of inflammatory mediators with premature atherosclerosis in rheumatoid arthritis and healthy controls: comment on the article by Rho et alPaul Welsh, Naveed Sattar, Mike Peters
Diabetes Care|June 9, 2016
Metformin Therapy and Circulating NT-proBNP Levels: The CAMERA TrialDavid Preiss, Paul Welsh, Naveed Sattar
Human Reproduction (Oxford, England)|March 1, 2014
A single-centre evaluation of two new anti-Mullerian hormone assays and comparison with the current clinical standard assayPaul Welsh, Karen Smith, Scott M Nelson
Circulation|August 25, 2025
Response by Ho et al to Letter Regarding Article, "A Proteomics-Based Approach for Prediction of Different Cardiovascular Diseases and Dementia"Frederick K Ho, Naveed Sattar, Paul Welsh
Pageof 33

Showing results (1-10 of 328) with videos related to

Sort By:
Pageof 33
Hypertension (Dallas, Tex. : 1979)|December 28, 2017
Correlating Changes in Metabolic Status With Arterial Health: Modest Associations but Any Clinical Implications?Paul Welsh
European Heart Journal|March 10, 2022
Risk scoring in secondary prevention: a basis for informed clinical decisions in the context of ever-expanding treatmentsNaveed Sattar, Paul Welsh
European Heart Journal|May 28, 2020
The obesity paradox in secondary prevention: a weighty intervention or a wait for more evidence?Naveed Sattar, Paul Welsh
BMJ (Clinical Research Ed.)|April 3, 2014
Vitamin D and chronic disease preventionPaul Welsh, Naveed Sattar
Clinical Chemistry|November 25, 2022
To ApoB or Not to ApoB: New Arguments, but Basis for Widespread Implementation Remains ElusivePaul Welsh, Naveed Sattar
BMJ (Clinical Research Ed.)|November 20, 2014
Vitamin D genes and mortalityPaul Welsh, Naveed Sattar
Arthritis Care & Research|July 1, 2010
Association of inflammatory mediators with premature atherosclerosis in rheumatoid arthritis and healthy controls: comment on the article by Rho et alPaul Welsh, Naveed Sattar, Mike Peters
Diabetes Care|June 9, 2016
Metformin Therapy and Circulating NT-proBNP Levels: The CAMERA TrialDavid Preiss, Paul Welsh, Naveed Sattar
Human Reproduction (Oxford, England)|March 1, 2014
A single-centre evaluation of two new anti-Mullerian hormone assays and comparison with the current clinical standard assayPaul Welsh, Karen Smith, Scott M Nelson
Circulation|August 25, 2025
Response by Ho et al to Letter Regarding Article, "A Proteomics-Based Approach for Prediction of Different Cardiovascular Diseases and Dementia"Frederick K Ho, Naveed Sattar, Paul Welsh
Pageof 33